Speaker
Head of Cancer Biology, EPICS Therapeutics
Andrea Casazza, Head of Cancer Biology at EPICS Therapeutics, is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “RNA Methyltransferase Inhibition Validates Epitranscriptomic Regulation as a Novel Approach in the Treatment of Solid Tumors”.
10–12 Nov 2026Boston, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Andrea Casazza, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].